PTCA | Across CTO RX
Outstanding crossability
- Lesion entry profile of 0.015’’ (0.38mm)
- Truly tapered tip with less than 2° inclination
-
- Minimize the risk of failure to cross a CTO lesion once the wire has reached the distal true lumen
Unsurpassed balloon strength
- High pressure balloon with RBP up to 25 atm
- Ultra-resistant to puncture
-
- Very robust balloon material, optimizing the success of dilating the often heavily calcified CTO lesions
|
 |
Excellent trackability and pushability
|
- “Tongue” technology design enhances transfer of strength from shaft to balloon area
- HydrolubricTM coating for minimal friction and optimal trackability
- Parallel Guide Wire Exit Port for optimal pushability
|
It's a medical device manufactured by: Acrostak (Schweiz) AG Stegackerstrasse 14 CH-8409 Winterthur SWITZERLAND
Distribuited by: CID S.p.A. Strada per Crescentino s.n. 13040 Saluggia, Italy
Not for sale in U.S.A. and Japan